Audited Financial Results along with Auditor''s report for the Financial Year Ended on 31.03.2025.
Awaiting price reaction for this filing.
Kashyap Tele-Medicines reported FY25 revenue from operations of just ₹3.90 lakhs, a sharp ~80% decline from ₹19.20 lakhs in FY24. The company posted a marginal loss after tax of ₹(0.03) lakhs, a slight improvement from a ₹(3.00) lakh loss last year. Operating cash flow worsened significantly to ₹(8.60) lakhs versus ₹(0.34) lakhs in FY24, and cash balance fell to just ₹0.37 lakhs from ₹8.97 lakhs. Other equity stands deeply negative at ₹(413.27) lakhs against share capital of ₹477.22 lakhs, indicating eroded net worth. The statutory auditor (Ravi Karia & Associates) issued an unmodified (clean) opinion on the results. The filing also includes a major board overhaul — Amit Agrawal (MD), Raghav Agrawal (Director and CFO), and Ayushman Khemka resigned citing pre-occupation, while Kalpesh Bipin Sheth was appointed as new MD, Heena Sheth as Whole-time Director, and Samir Ambavi as Additional Non-executive Director.
The collapsed revenue, deeply negative net worth, and worsening cash burn are significant red flags for shareholders despite a clean audit opinion. The exit of the previous promoter-family management and replacement with a new group could signal a strategic pivot, but investors should watch closely for any business revival or further deterioration.